Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David F. Claxton"'
Autor:
Borje S. Andersson, J. Cox, Fernando Cabanillas, Paolo Anderlini, Fredrick B. Hagemeister, Chitra Hosing, K. Van Besien, Sergio Giralt, Donna Przepiorka, Richard E. Champlin, Uday R. Popat, David F. Claxton, J. Romaguera, Issa F. Khouri, James Gajewski, Chul S. Ha, Rima M. Saliba, Maria Alma Rodriguez
Publikováno v:
Bone Marrow Transplantation. 33:1015-1023
Our purpose was to study the risk factors associated with disease progression after high-dose chemotherapy followed by autologous stem cell transplantation in patients with recurrent or refractory Hodgkin's lymphoma (HL). We analyzed the long-term ou
Autor:
Sergio Giralt, Susan O'Brien, Paolo Anderlini, M. Davis, Naoto T. Ueno, Borje S. Andersson, James Gajewski, Farhad Ravandi, Hagop M. Kantarjian, M. Korbling, David F. Claxton, M. Donato, A. Cohen, Issa F. Khouri, D. DeVos, Richard E. Champlin
Publikováno v:
Bone Marrow Transplantation. 27:1221-1225
Relapse after allogeneic progenitor cell transplant is associated with a poor prognosis for patients with advanced leukemia, with few curative options available. Use of novel chemotherapeutic agents with limited toxicity is warranted. We investigated
Autor:
Naoto T. Ueno, Borje S. Andersson, Paolo Anderlini, David F. Claxton, Donna Przepiorka, Adrian P. Gee, Michael J. Keating, Cindy Ippoliti, B. Von Wolff, Sergio Giralt, Susan O'Brien, M. Donato, Richard E. Champlin, Issa F. Khouri, M. Korbling, James Gajewski
Publikováno v:
Journal of Clinical Oncology. 16:2817-2824
PURPOSE To investigate the use of a nonmyeloablative fludarabine-based preparative regimen to produce sufficient immunosuppression to allow engraftment of allogeneic stem cells and induction of graft-versus-leukemia/lymphoma (GVL) as the primary trea
Autor:
Junjia Zhu, K Lucas, Joseph Mierski, Kamal Kant Singh Abbi, Giampaolo Talamo, M Carraher, David F. Claxton, Elliot E Epner, Witold B. Rybka, W. C. Ehmann
Publikováno v:
Bone marrow transplantation. 48(3)
There is little data comparing the activity and toxicity of donor lymphocyte therapy with granulocyte (G)-CSF-mobilized cells (G-donor lymphocyte infusion (DLI)) with the conventionally collected DLI (C-DLI) after allogeneic blood or marrow transplan
Autor:
Richard E. Champlin, K. W. Chan, Ira Braunschweig, Issa F. Khouri, Cindy Ippoliti, Paolo Anderlini, James Gajewski, Borje S. Andersson, M. Donato, K. Van Besien, Rakesh Mehra, David F. Claxton, M. Korbling, Sergio Giralt, Naoto T. Ueno, Karen R. Cleary, H. Fischer, Donna Przepiorka
Publikováno v:
Bone marrow transplantation. 24(7)
Thirty adults with leukemia or lymphoma transplanted with marrow or blood stem cells from 1-antigen mismatched related donors received tacrolimus and minidose methotrexate to prevent acute graft-versus-host disease (GVHD). The group had a median age